Global Healthcare and Pharma Market Outlook

Obesity and T2D drugs drive Novo Nordisk and Eli Lilly Q2 2023 growth

The market cap for both companies will continue to grow in line with the increasing growth projections for Lilly’s Mounjaro and Novo’s Wegovy and Ozempic.


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.